Amoéba secures market authorization in France

Amoéba has received authorization to market its biocide product in France.

Published 6sem1 sourceNotableupdated 3j

≈ 14sSpeed

The fact

This approval targets treatment against Legionella and pathogenic amoebae.

The stock reacted positively to this announcement on the markets.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on June 30, 2026